Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria

被引:0
|
作者
Linklater, H. [1 ]
Pipitone, N. [2 ]
Rose, M. R. [3 ]
Norwood, F. [3 ]
Campbell, R. [1 ]
Salvarani, C. [2 ]
Scott, D. L. [1 ]
Gordon, P. [1 ]
机构
[1] Kings Coll Hosp NHS Fdn Trust, Dept Rheumatol, London SE5 9RS, England
[2] Azienda Osped ASMN, Rheumatol Unit, Dept Internal Med, Ist Ricovero & Cura Carattere Sci, Reggio Emilia, Italy
[3] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London SE5 9RS, England
关键词
myositis; polymyositis; dermatomyositis; inclusion body myositis; classification; POLYMYOSITIS; CLASSIFICATION; EPIDEMIOLOGY; AUTOANTIBODIES; MYOSITIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Various criteria have been proposed to classify the inflammatory myositides (IIMs) polymyositis (PM) and dermatomyositis (DM). However, none have received universal acceptance. Our aim was to assess the performance of the main criteria used to classify IIM. Specialist consultant diagnosis was considered the gold standard. Methods. Patients attending King's College Hospital (KCH) or Reggio Emilia Hospital (REH) since 1990 with a diagnosis of IIM or non-inflammatory myopathy were identified, and their records and laboratory investigations retrospectively reviewed. Where the complete data required for the classification criteria or a final physician diagnosis was unavailable, patients were excluded. 52 patients with a specialist diagnosis of PM, DM, inclusion body myositis (IBM) or non-inflammatory myopathy were included. Agreement between specialist consultant diagnosis and classification criteria was measured using Cohen's kappa (K) statistics. Sensitivity and specificity were also calculated. Results. The Dalakas (2003) criteria demonstrated substantial agreement with specialist diagnosis: kappa=0.69, sensitivity 77%, specificity 99%. The European Neuromuscular Centre criteria (ENMC) demonstrated fair agreement: kappa=0.49, sensitivity 71%, specificity 82%. Other criteria performed less well. In particular, the Bohan and Peter criteria demonstrated a specificity of only 29%. Conclusions. The criteria of Dalakas (2003) agreed best with specialist consultant diagnosis. The criteria of Bohan and Peter demonstrated very poor specificity. Prospective studies are required to develop improved classification criteria.
引用
收藏
页码:767 / 769
页数:3
相关论文
共 50 条
  • [31] Cancer screening in idiopathic inflammatory myopathies: Ten years experience from a single center
    Trallero-Araguas, Ernesto
    Gil-Vila, Albert
    Martinez-Gomez, X.
    Pinal-Fernandez, Iago
    Alvarado-Cardenas, M.
    Simo-Perdigo, M.
    Selva-O'Callaghan, Albert
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 53
  • [32] Biologics for idiopathic inflammatory myopathies
    Moghadam-Kia, Siamak
    Aggarwal, Rohit
    Oddis, Chester V.
    CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (06) : 645 - 651
  • [33] Predictors of cardiac involvement in idiopathic inflammatory myopathies
    Bandeira, Matilde
    Dourado, Eduardo
    Melo, Ana Teresa
    Martins, Patricia
    Fraga, Vanessa
    Ferraro, Jose Luis
    Saraiva, Andre
    Sousa, Marlene
    Parente, Hugo
    Soares, Catarina
    Correia, Ana Margarida
    Almeida, Diogo Esperanca
    Dinis, Sara Paiva
    Pinto, Ana Sofia
    Pinheiro, Filipe Oliveira
    Rato, Maria Seabra
    Beirao, Tiago
    Samoes, Beatriz
    Santos, Bernardo
    Mazeda, Carolina
    Chicharo, Ana Teodosio
    Faria, Margarida
    Neto, Agna
    Lourenco, Maria Helena
    Brites, Luisa
    Rodrigues, Marilia
    Silva-Dinis, Joana
    Dias, Joao Madruga
    Araujo, Filipe C.
    Martins, Nadia
    Couto, Maura
    Valido, Ana
    Santos, Maria Jose
    Barreira, Sofia Carvalho
    Fonseca, Joao Eurico
    Campanilho-Marques, Raquel
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [34] Resistin in idiopathic inflammatory myopathies
    Filkova, Maria
    Hulejova, Hana
    Kuncova, Klara
    Plestilova, Lenka
    Cerezo, Lucie Andres
    Mann, Herman
    Klein, Martin
    Zamecnik, Josef
    Gay, Steffen
    Vencovsky, Jiri
    Senolt, Ladislav
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (03)
  • [35] Clinical presentation and therapy of idiopathic inflammatory myopathies
    Miller, FW
    JOURNAL OF MUSCULOSKELETAL PAIN, 2004, 12 (3-4): : 85 - 91
  • [36] Idiopathic Inflammatory Myopathies: Updates on Diagnosis and Classification
    Tomaras, Stylianos
    Kekow, Joern
    Feist, Eugen
    AKTUELLE RHEUMATOLOGIE, 2021, 46 (04) : 361 - 372
  • [37] From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies
    Mcleish, Emily
    Slater, Nataliya
    Mastaglia, Frank L.
    Needham, Merrilee
    Coudert, Jerome D.
    BRIEFINGS IN BIOINFORMATICS, 2024, 25 (01)
  • [38] Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies
    Argyriou, Alexandra
    Horuluoglu, Begum
    Galindo-Feria, Angeles Shunashy
    Diaz-Boada, Juan Sebastian
    Sijbranda, Merel
    Notarnicola, Antonella
    Dani, Lara
    van Vollenhoven, Annika
    Ramskold, Daniel
    Nennesmo, Inger
    Dastmalchi, Maryam
    Lundberg, Ingrid E.
    Diaz-Gallo, Lina-Marcela
    Chemin, Karine
    EMBO MOLECULAR MEDICINE, 2023, 15 (10)
  • [39] Early Illness Features Associated With Mortality in the Juvenile Idiopathic Inflammatory Myopathies
    Huber, Adam M.
    Mamyrova, Gulnara
    Lachenbruch, Peter A.
    Lee, Julia A.
    Katz, James D.
    Targoff, Ira N.
    Miller, Frederick W.
    Rider, Lisa G.
    ARTHRITIS CARE & RESEARCH, 2014, 66 (05) : 732 - 740
  • [40] Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients
    Chung, Sang Wan
    Yoo, In Seol
    Kim, Jinhyun
    Kang, Seong Wook
    Kwon, Mihye
    Joung, Chung-Il
    Choi, In Ah
    Chang, Sung Hae
    Kang, Mi Il
    Hong, Seung-Jae
    Lee, Yeon-Ah
    YONSEI MEDICAL JOURNAL, 2021, 62 (05) : 424 - 430